Journals / Turkish Journal of Pediatrics / 2016 / Cilt: 58 - Sayı: 2

Evaluation of the removal reasons of totally implantable venous devices in children: a retrospective study

Pages
187–194
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is a positive correlation between BMI and infections (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:SUMMARY: Kılıç S, Soyer T, Karnak İ, Çiftçi AÖ, Tanyel FC, Şenocak ME.
📊
Key Findings & Data:Turk J Pediatr 2016; 58: 187-194.
💡
Conclusion & Impact:There is a positive correlation between BMI and infections (p
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

SUMMARY: Kılıç S, Soyer T, Karnak İ, Çiftçi AÖ, Tanyel FC, Şenocak ME. Evaluation of the removal reasons of totally implantable venous devices in children: a retrospective study. Turk J Pediatr 2016; 58: 187-194. Totally implantable venous access devices (TIVADs) increase the quality of life in children with hematologic and oncologic diseases or organ failures. The aim of this study is to determine the reasons for port removal. The port catheters, implanted and removed in patients between January 2000 and June 2013 were evaluated retrospectively. The patients were divided into two groups, whose port catheters were removed due to completed therapy (completed therapy group, CTG) and whose port catheters were removed because of a port catheter-related complications (complication group, CG). In the CG, the patients whose port catheters are removed for infectious reasons are investigated for whether there is a relationship with age, gender, body mass index (BMI), height and weight at the time of port implantation and removal. In total, 242 patients who underwent port implantation and removal were included in the study. The male to female ratio was 1.32/1 and the mean age of the patients was 9.4±4.9 years (0-24 year). Patients were enrolled in CTG (n=170, 70.2%), and CG (n=72, 29%). There is a positive correlation between BMI and infections (p

🔖

Cite This Article

KARNAK, İ., TANYEL, F. C., SOYER, T., KILIÇ, S., ŞENOCAK, M. E., ÇİFTÇİ, A. Ö. (2022). Evaluation of the removal reasons of totally implantable venous devices in children: a retrospective study. Turkish Journal of Pediatrics, Cilt: 58 - Sayı: 2, 187–194. https://ajindex.com/articles/613209

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Funaki B. Central venous access: a primer for the diagnostic radiologist. AJR Am J Roentgenol 2002; 179: 309-318
  2. Biffi R, Toro A, Pozzi S, Di Carlo I. Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved? Support Care Cancer 2014; 22: 1705-1714
  3. Coppa GF, Gouge TH, Hofstetter SR. Air embolism: a lethal but preventable complication of subclavian vein catheterization. JPEN J Parenter Enteral Nutr 1981; 5: 166-168
  4. Ezaru CS, Mangione MP, Oravitz TM, Ibinson JW, Bjerke RJ. Eliminating arterial injury during central venous catheterization using manometry. Anesth Analg 2009; 109: 130-134
  5. Faraj W, Zaghal A, El-Beyrouthy O, Kutoubi A. Complete catheter disconnection and migration of an implantable venous access device: the disconnected cap sign. Ann Vasc Surg 2010; 24: 692.e11-e15
  6. Burns S, Herbison GJ. Spinal accessory nerve injury as a complication of internal jugular vein cannulation. Ann Intern Med 1996; 125: 700
  7. Wiegand UK, LeJeune D, Boguschewski F, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/ anticoagulation therapy. Chest 2004; 126: 1177-1186
  8. Zawacki WJ, Walker TG, DeVasher E, et al. Wound dehiscence or failure to heal following venous access port placement in patients receiving bevacizumab therapy. J Vasc Interv Radiol 2009; 20: 624-627
  9. Flynn PM, Shenep JL, Stokes DC, Barrett FF. In situ management of confirmed central venous catheterrelated bacteremia. Pediatr Infect Dis J 1987; 6: 729- 734. 10. de Jonge RC, Polderman KH, Gemke RJ. Central venous catheter use in the pediatric patient: mechanical and infectious complications. Pediatr Crit Care Med 2005; 6: 329-339
  10. Lokich JJ, Bothe A Jr, Benotti P, Moore C. Complications and management of implanted venous access catheters. J Clin Oncol 1985; 3: 710-717
  11. Kurul S, Saip P, Aydin T. Totally implantable venousaccess ports: local problems and extravasation injury. Lancet Oncol 2002; 3: 684-692
  12. Biffi R, de Braud F, Orsi F, et al. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 1998; 9: 767-773
  13. Jueckstock JK, Mylonas I, Strobl B, Willgeroth F, Sommer HL, Friese K. Paravasation with cyclophosphamide – case report of tissue nec